Related Experiment Video
Updated: Aug 10, 2026

12:19
Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
Published on: June 27, 2015
Light-chain binding sites on renal brush-border membranes
V Batuman1, A W Dreisbach, J Cyran
1Medical Service, Veterans Administration Medical Center, East Orange 07019.
The American Journal of Physiology
|May 1, 1990
Summary
Immunoglobulin light chains bind to kidney brush-border membranes via specific receptors. This binding suggests a role in the uptake and processing of these proteins by renal tubules, potentially impacting kidney function.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Immunoglobulin light chains are filtered by the kidneys and processed by proximal tubular cells.
- Excessive light chain production and excretion are linked to kidney dysfunction and can impair tubular function.
- The interaction of light chains with renal proximal tubules requires further elucidation.
Purpose of the Study:
- To investigate the binding characteristics of immunoglobulin light chains to renal proximal tubular brush-border membranes.
- To identify the nature and selectivity of binding sites for light chains on kidney membranes.
- To explore the potential physiological role of these binding interactions.
Main Methods:
- Utilized 125I-labeled kappa- and lambda-light chains from multiple myeloma patients.
- Assessed binding to rat and human renal proximal tubular brush-border membranes.
- Employed flow cytometry for immunological demonstration of light-chain binding.
- Analyzed binding data using computer modeling to determine binding site characteristics.
Main Results:
- Identified a single class of low-affinity, high-capacity binding sites for light chains on both rat and human kidney brush-border membranes.
- Dissociation constants ranged from 1.6 X 10(-5) to 1.2 X 10(-4) M, with maximum binding capacity between 4.7-8.0 X 10(-8) mol/mg protein.
- Light chains competed with each other for binding, and showed relative selectivity over albumin and beta-lactoglobulin.
Conclusions:
- Renal brush-border membranes possess specific binding sites for immunoglobulin light chains.
- These sites likely function as endocytotic receptors, mediating the uptake of light chains by proximal tubular cells.
- This interaction may be crucial for the catabolism of light chains and potentially other low-molecular-weight proteins in the kidney.
More Related Videos
Related Concept Videos
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...

